hhex Search Results


88
Thermo Fisher gene exp hhex hs00242160 m1
Gene Exp Hhex Hs00242160 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp hhex hs00242160 m1/product/Thermo Fisher
Average 88 stars, based on 1 article reviews
gene exp hhex hs00242160 m1 - by Bioz Stars, 2026-03
88/100 stars
  Buy from Supplier

93
R&D Systems hhex
Immunocytochemistry for development-related organ-enriched markers (KRT14, TBX20, FOXA2, <t>HHEX,</t> FOXD1, PAX8, and RSPO) on adult fibroblasts obtained from different organs of Col1a1-GFP mice and cultured for 5 days: ( a ) Skin fibroblasts stained with a <t>mouse</t> <t>monoclonal</t> anti-KRT14 antibody; ( b ) heart fibroblasts stained with a mouse monoclonal anti-TBX20 antibody; ( c ) lung fibroblasts stained with a rabbit monoclonal anti-FOXA2 antibody; ( d ) liver fibroblasts stained with a rabbit monoclonal anti-HHEX antibody; ( e ) kidney fibroblasts stained with a rabbit polyclonal anti-FOXD1 antibody; ( f ) kidney fibroblasts stained with a mouse monoclonal anti-PAX8 antibody; ( g ) testis fibroblasts stained with a goat polyclonal anti-RSPO1 antibody. As secondary antibodies, goat anti-mouse Alexa Fluor 568 was used for ( a , b ), ( f ); goat anti-rabbit Alexa Fluor 555 for ( c , d ) and donkey anti-goat Alexa Fluor 568 for ( f ). Representative images from three independent experiments on three biological replicates. Scale bar = 100 µm. Refer to .
Hhex, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hhex/product/R&D Systems
Average 93 stars, based on 1 article reviews
hhex - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Thermo Fisher gene exp hhex hs01074519 m1
( A ) Left: Representative in silico 3D transcriptomic analysis showing co-expression of FUT1 with pluripotent markers (NANOG, SOX2, and OCT3/4) on E6.0 in sections #351–370 from a sequential series of sections. Right: 2D corn plots showing FUT1 and pluripotent gene expression on E6.0. Abbreviations represent A, anterior ; P, posterior; L, left; R, right; Pr, proximal; D, distal. ( B ) 2D corn plots showing the expression of ectoderm markers, OTX2, PAX6, ZIC1, SOX2, SOX1, HOXC8, PHOX2b, OLIG2, PAX7, HOXB9, and DBX1 on E7.5 embryos. ( C ) 2D corn plots showing the expression of DE markers, <t>HHEX,</t> FOXA2, SOX17, and FOXA1 on E7.5. ( D ) 2D corn plots showing the spatiotemporal expression mesoderm genes, BRY (T gene) and MIXL1 on E7.0–E7.5; HOPX, NKX2.5, ISL1, HAND1, IRX3, MESP2, FOXC1, FOXF1, and CDX2 on E7.5. 2D and 3D gene expression analysis was obtained by using the database of mouse gastrulation on E5.5–E7.5 ( http://egastrulation.sibcb.ac.cn ).
Gene Exp Hhex Hs01074519 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp hhex hs01074519 m1/product/Thermo Fisher
Average 93 stars, based on 1 article reviews
gene exp hhex hs01074519 m1 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Thermo Fisher snp hhex c 11214581 10
( A ) Left: Representative in silico 3D transcriptomic analysis showing co-expression of FUT1 with pluripotent markers (NANOG, SOX2, and OCT3/4) on E6.0 in sections #351–370 from a sequential series of sections. Right: 2D corn plots showing FUT1 and pluripotent gene expression on E6.0. Abbreviations represent A, anterior ; P, posterior; L, left; R, right; Pr, proximal; D, distal. ( B ) 2D corn plots showing the expression of ectoderm markers, OTX2, PAX6, ZIC1, SOX2, SOX1, HOXC8, PHOX2b, OLIG2, PAX7, HOXB9, and DBX1 on E7.5 embryos. ( C ) 2D corn plots showing the expression of DE markers, <t>HHEX,</t> FOXA2, SOX17, and FOXA1 on E7.5. ( D ) 2D corn plots showing the spatiotemporal expression mesoderm genes, BRY (T gene) and MIXL1 on E7.0–E7.5; HOPX, NKX2.5, ISL1, HAND1, IRX3, MESP2, FOXC1, FOXF1, and CDX2 on E7.5. 2D and 3D gene expression analysis was obtained by using the database of mouse gastrulation on E5.5–E7.5 ( http://egastrulation.sibcb.ac.cn ).
Snp Hhex C 11214581 10, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/snp hhex c 11214581 10/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
snp hhex c 11214581 10 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

85
Thermo Fisher gene exp hhex mm00433954 m1
( A ) Left: Representative in silico 3D transcriptomic analysis showing co-expression of FUT1 with pluripotent markers (NANOG, SOX2, and OCT3/4) on E6.0 in sections #351–370 from a sequential series of sections. Right: 2D corn plots showing FUT1 and pluripotent gene expression on E6.0. Abbreviations represent A, anterior ; P, posterior; L, left; R, right; Pr, proximal; D, distal. ( B ) 2D corn plots showing the expression of ectoderm markers, OTX2, PAX6, ZIC1, SOX2, SOX1, HOXC8, PHOX2b, OLIG2, PAX7, HOXB9, and DBX1 on E7.5 embryos. ( C ) 2D corn plots showing the expression of DE markers, <t>HHEX,</t> FOXA2, SOX17, and FOXA1 on E7.5. ( D ) 2D corn plots showing the spatiotemporal expression mesoderm genes, BRY (T gene) and MIXL1 on E7.0–E7.5; HOPX, NKX2.5, ISL1, HAND1, IRX3, MESP2, FOXC1, FOXF1, and CDX2 on E7.5. 2D and 3D gene expression analysis was obtained by using the database of mouse gastrulation on E5.5–E7.5 ( http://egastrulation.sibcb.ac.cn ).
Gene Exp Hhex Mm00433954 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp hhex mm00433954 m1/product/Thermo Fisher
Average 85 stars, based on 1 article reviews
gene exp hhex mm00433954 m1 - by Bioz Stars, 2026-03
85/100 stars
  Buy from Supplier

86
Thermo Fisher gene exp olig3 mm02525085 s1
( A ) Left: Representative in silico 3D transcriptomic analysis showing co-expression of FUT1 with pluripotent markers (NANOG, SOX2, and OCT3/4) on E6.0 in sections #351–370 from a sequential series of sections. Right: 2D corn plots showing FUT1 and pluripotent gene expression on E6.0. Abbreviations represent A, anterior ; P, posterior; L, left; R, right; Pr, proximal; D, distal. ( B ) 2D corn plots showing the expression of ectoderm markers, OTX2, PAX6, ZIC1, SOX2, SOX1, HOXC8, PHOX2b, OLIG2, PAX7, HOXB9, and DBX1 on E7.5 embryos. ( C ) 2D corn plots showing the expression of DE markers, <t>HHEX,</t> FOXA2, SOX17, and FOXA1 on E7.5. ( D ) 2D corn plots showing the spatiotemporal expression mesoderm genes, BRY (T gene) and MIXL1 on E7.0–E7.5; HOPX, NKX2.5, ISL1, HAND1, IRX3, MESP2, FOXC1, FOXF1, and CDX2 on E7.5. 2D and 3D gene expression analysis was obtained by using the database of mouse gastrulation on E5.5–E7.5 ( http://egastrulation.sibcb.ac.cn ).
Gene Exp Olig3 Mm02525085 S1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp olig3 mm02525085 s1/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
gene exp olig3 mm02525085 s1 - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

93
Atlas Antibodies rabbit anti human hhex
mRNA and protein expression of <t>HHEX.</t> ( A ) mRNA expression in controls, multiple sclerosis (MS) patients, and MS patients stratified by treatment. Controls: n = 117; MS patients: n = 154; MS patients treated with IFN-β: n = 94; MS patients treated with glatiramer acetate: n = 57. ( B ) HHEX mRNA expression in controls and MS patients stratified by rs7923837 genotype. Heterozygotes were grouped with major homozygotes due to similar expression levels. Control GG + GA: n = 101; minor allele homozygous controls AA: n = 16; MS GG + GA: n = 133; MS AA: n = 18; MS GG + GA treated with IFN-β: n = 85; MS AA treated with IFN-β: n = 9; MS GG + GA treated with glatiramer acetate: n = 48; MS AA treated with glatiramer acetate: n = 9. ( C ) Expression of HHEX protein analyzed by Western blot, stratified by rs7923837 genotype. Control GG + GA: n = 24; Control AA: n = 9; MS GG + GA: n = 36; MS AA: n = 13. Mean and standard deviation are presented in all panels.
Rabbit Anti Human Hhex, supplied by Atlas Antibodies, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti human hhex/product/Atlas Antibodies
Average 93 stars, based on 1 article reviews
rabbit anti human hhex - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Red Star Corporation hhex-redstar
mRNA and protein expression of <t>HHEX.</t> ( A ) mRNA expression in controls, multiple sclerosis (MS) patients, and MS patients stratified by treatment. Controls: n = 117; MS patients: n = 154; MS patients treated with IFN-β: n = 94; MS patients treated with glatiramer acetate: n = 57. ( B ) HHEX mRNA expression in controls and MS patients stratified by rs7923837 genotype. Heterozygotes were grouped with major homozygotes due to similar expression levels. Control GG + GA: n = 101; minor allele homozygous controls AA: n = 16; MS GG + GA: n = 133; MS AA: n = 18; MS GG + GA treated with IFN-β: n = 85; MS AA treated with IFN-β: n = 9; MS GG + GA treated with glatiramer acetate: n = 48; MS AA treated with glatiramer acetate: n = 9. ( C ) Expression of HHEX protein analyzed by Western blot, stratified by rs7923837 genotype. Control GG + GA: n = 24; Control AA: n = 9; MS GG + GA: n = 36; MS AA: n = 13. Mean and standard deviation are presented in all panels.
Hhex Redstar, supplied by Red Star Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hhex-redstar/product/Red Star Corporation
Average 90 stars, based on 1 article reviews
hhex-redstar - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ABclonal Biotechnology hhex a19689 antibody
mRNA and protein expression of <t>HHEX.</t> ( A ) mRNA expression in controls, multiple sclerosis (MS) patients, and MS patients stratified by treatment. Controls: n = 117; MS patients: n = 154; MS patients treated with IFN-β: n = 94; MS patients treated with glatiramer acetate: n = 57. ( B ) HHEX mRNA expression in controls and MS patients stratified by rs7923837 genotype. Heterozygotes were grouped with major homozygotes due to similar expression levels. Control GG + GA: n = 101; minor allele homozygous controls AA: n = 16; MS GG + GA: n = 133; MS AA: n = 18; MS GG + GA treated with IFN-β: n = 85; MS AA treated with IFN-β: n = 9; MS GG + GA treated with glatiramer acetate: n = 48; MS AA treated with glatiramer acetate: n = 9. ( C ) Expression of HHEX protein analyzed by Western blot, stratified by rs7923837 genotype. Control GG + GA: n = 24; Control AA: n = 9; MS GG + GA: n = 36; MS AA: n = 13. Mean and standard deviation are presented in all panels.
Hhex A19689 Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hhex a19689 antibody/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
hhex a19689 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GeneTex anti-csnk2a1 antibodies gtx84369
Quantitative real-time reverse transcription polymerase chain reaction analysis of the <t>CSNK2A1</t> gene in the liver tissues of control (+Dock7 m /+Dock7 m ) and T2DM (+Lepr db /+Lepr db ) mice at 4, 16, and 32 weeks. Gene expression data of CSNK2A1 was calculated after normalizing against GADPH (**, P < 0.05).
Anti Csnk2a1 Antibodies Gtx84369, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-csnk2a1 antibodies gtx84369/product/GeneTex
Average 90 stars, based on 1 article reviews
anti-csnk2a1 antibodies gtx84369 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Immunocytochemistry for development-related organ-enriched markers (KRT14, TBX20, FOXA2, HHEX, FOXD1, PAX8, and RSPO) on adult fibroblasts obtained from different organs of Col1a1-GFP mice and cultured for 5 days: ( a ) Skin fibroblasts stained with a mouse monoclonal anti-KRT14 antibody; ( b ) heart fibroblasts stained with a mouse monoclonal anti-TBX20 antibody; ( c ) lung fibroblasts stained with a rabbit monoclonal anti-FOXA2 antibody; ( d ) liver fibroblasts stained with a rabbit monoclonal anti-HHEX antibody; ( e ) kidney fibroblasts stained with a rabbit polyclonal anti-FOXD1 antibody; ( f ) kidney fibroblasts stained with a mouse monoclonal anti-PAX8 antibody; ( g ) testis fibroblasts stained with a goat polyclonal anti-RSPO1 antibody. As secondary antibodies, goat anti-mouse Alexa Fluor 568 was used for ( a , b ), ( f ); goat anti-rabbit Alexa Fluor 555 for ( c , d ) and donkey anti-goat Alexa Fluor 568 for ( f ). Representative images from three independent experiments on three biological replicates. Scale bar = 100 µm. Refer to .

Journal: eLife

Article Title: Adult mouse fibroblasts retain organ-specific transcriptomic identity

doi: 10.7554/eLife.71008

Figure Lengend Snippet: Immunocytochemistry for development-related organ-enriched markers (KRT14, TBX20, FOXA2, HHEX, FOXD1, PAX8, and RSPO) on adult fibroblasts obtained from different organs of Col1a1-GFP mice and cultured for 5 days: ( a ) Skin fibroblasts stained with a mouse monoclonal anti-KRT14 antibody; ( b ) heart fibroblasts stained with a mouse monoclonal anti-TBX20 antibody; ( c ) lung fibroblasts stained with a rabbit monoclonal anti-FOXA2 antibody; ( d ) liver fibroblasts stained with a rabbit monoclonal anti-HHEX antibody; ( e ) kidney fibroblasts stained with a rabbit polyclonal anti-FOXD1 antibody; ( f ) kidney fibroblasts stained with a mouse monoclonal anti-PAX8 antibody; ( g ) testis fibroblasts stained with a goat polyclonal anti-RSPO1 antibody. As secondary antibodies, goat anti-mouse Alexa Fluor 568 was used for ( a , b ), ( f ); goat anti-rabbit Alexa Fluor 555 for ( c , d ) and donkey anti-goat Alexa Fluor 568 for ( f ). Representative images from three independent experiments on three biological replicates. Scale bar = 100 µm. Refer to .

Article Snippet: Primary antibodies used in this study are: KRT14 (MA5-11599, Thermo Fisher, mouse monoclonal, 1:100), TBX20 (MAB8124, Novus Biologicals, mouse monoclonal, 1:200), FOXA2 (ab108422, Abcam, rabbit monoclonal, 1:300), HHEX (MAB83771, R&D System, rabbit monoclonal, 1:100), FOXD1 (TA322737, OriGene, rabbit polyclonal, 1:50), PAX8 (NBP2-29903, Novus Biological, mouse monoclonal, 1:100), RSPO1 (AF3474, R&D Novus, goat polyclonal, 1:50), and TNT (RC-C2, DSHB 1:200).

Techniques: Immunocytochemistry, Cell Culture, Staining

( A ) Left: Representative in silico 3D transcriptomic analysis showing co-expression of FUT1 with pluripotent markers (NANOG, SOX2, and OCT3/4) on E6.0 in sections #351–370 from a sequential series of sections. Right: 2D corn plots showing FUT1 and pluripotent gene expression on E6.0. Abbreviations represent A, anterior ; P, posterior; L, left; R, right; Pr, proximal; D, distal. ( B ) 2D corn plots showing the expression of ectoderm markers, OTX2, PAX6, ZIC1, SOX2, SOX1, HOXC8, PHOX2b, OLIG2, PAX7, HOXB9, and DBX1 on E7.5 embryos. ( C ) 2D corn plots showing the expression of DE markers, HHEX, FOXA2, SOX17, and FOXA1 on E7.5. ( D ) 2D corn plots showing the spatiotemporal expression mesoderm genes, BRY (T gene) and MIXL1 on E7.0–E7.5; HOPX, NKX2.5, ISL1, HAND1, IRX3, MESP2, FOXC1, FOXF1, and CDX2 on E7.5. 2D and 3D gene expression analysis was obtained by using the database of mouse gastrulation on E5.5–E7.5 ( http://egastrulation.sibcb.ac.cn ).

Journal: EMBO Reports

Article Title: Terminal α1,2-fucosylation of glycosphingolipids by FUT1 is a key regulator in early cell-fate decisions

doi: 10.1038/s44319-024-00243-1

Figure Lengend Snippet: ( A ) Left: Representative in silico 3D transcriptomic analysis showing co-expression of FUT1 with pluripotent markers (NANOG, SOX2, and OCT3/4) on E6.0 in sections #351–370 from a sequential series of sections. Right: 2D corn plots showing FUT1 and pluripotent gene expression on E6.0. Abbreviations represent A, anterior ; P, posterior; L, left; R, right; Pr, proximal; D, distal. ( B ) 2D corn plots showing the expression of ectoderm markers, OTX2, PAX6, ZIC1, SOX2, SOX1, HOXC8, PHOX2b, OLIG2, PAX7, HOXB9, and DBX1 on E7.5 embryos. ( C ) 2D corn plots showing the expression of DE markers, HHEX, FOXA2, SOX17, and FOXA1 on E7.5. ( D ) 2D corn plots showing the spatiotemporal expression mesoderm genes, BRY (T gene) and MIXL1 on E7.0–E7.5; HOPX, NKX2.5, ISL1, HAND1, IRX3, MESP2, FOXC1, FOXF1, and CDX2 on E7.5. 2D and 3D gene expression analysis was obtained by using the database of mouse gastrulation on E5.5–E7.5 ( http://egastrulation.sibcb.ac.cn ).

Article Snippet: HHEX , Hematopoietically-expressed homeobox , HHEX , Hs01074519_m1.

Techniques: In Silico, Expressing, Gene Expression

( A ) Up at left: Quantification of pluripotent gene expression as measured by qPCR. Up at right: Quantification of the percentage of hESCs and hESCs-derived DE on day 8 showing the expression of OCT3/4 in histograms, bar chart, and MFI relative to hESCs. Bottom: Quantification of the percentage of hESCs and hESCs-derived DE on day 8 showing the expression of NANOG in histograms, bar chart, and MFI relative to hESCs. n = 4 technical replicates. ( B ) Up and bottom at left: Quantification of DE-specific markers, FOXA2 and SOX17 as measured by qPCR after hESC differentiation into DE using protocol 1, and FOXA2, SOX17, and HHEX as measured by qPCR after hESC differentiation into DE using protocol 2 ( n = 3 technical replicates). Bottom at right: Quantification of the percentage of hESCs and hESCs-derived DE on day 8 showing the expression of α-FP in histograms and bar chart and MFI relative to hESCs. ( C ) Up at left: Schematic illustration of hESC differentiation into NPCs via bFGF and RA signaling and BMP inhibition over 6 d. Up at right: Representative immunofluorescent cultures illustrate day 6 NPCs expressing OTX2 (green) and PAX6 (red). Nuclei are stained with DAPI (blue). Scale bars represent 100 μm. Bottom: qRT-PCR and flow cytometry analyses of OCT3/4, PAX6, SOX1. The expression of FUT1 and α-fucose in iPSCs during pluripotency and differentiation is identical to that of hESCs ( D ) Quantification of the percent of positive cells expressing both the FT1 and OCT3/4 proteins and MFI in hESCs, a pool of hiPSCs and a pool of human fibroblasts. Pooled sample, n = 3 cell lines. n = 3 technical replicates. ( E ) Quantification of the percent of positive cells expressing FT1 protein and α-fucose residues and MFI in hESCs, a pool of hiPSCs, and a pool of human fibroblasts. Pooled sample, n = 3 cell lines. n = 3 technical replicates. Data information: In qPCR ( A , B ), data are presented as means ± SD. Two-tailed Student’s t-tests * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. In FACS ( A – E ), data are presented as means ± SD. Ordinary One-way ANOVA ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Journal: EMBO Reports

Article Title: Terminal α1,2-fucosylation of glycosphingolipids by FUT1 is a key regulator in early cell-fate decisions

doi: 10.1038/s44319-024-00243-1

Figure Lengend Snippet: ( A ) Up at left: Quantification of pluripotent gene expression as measured by qPCR. Up at right: Quantification of the percentage of hESCs and hESCs-derived DE on day 8 showing the expression of OCT3/4 in histograms, bar chart, and MFI relative to hESCs. Bottom: Quantification of the percentage of hESCs and hESCs-derived DE on day 8 showing the expression of NANOG in histograms, bar chart, and MFI relative to hESCs. n = 4 technical replicates. ( B ) Up and bottom at left: Quantification of DE-specific markers, FOXA2 and SOX17 as measured by qPCR after hESC differentiation into DE using protocol 1, and FOXA2, SOX17, and HHEX as measured by qPCR after hESC differentiation into DE using protocol 2 ( n = 3 technical replicates). Bottom at right: Quantification of the percentage of hESCs and hESCs-derived DE on day 8 showing the expression of α-FP in histograms and bar chart and MFI relative to hESCs. ( C ) Up at left: Schematic illustration of hESC differentiation into NPCs via bFGF and RA signaling and BMP inhibition over 6 d. Up at right: Representative immunofluorescent cultures illustrate day 6 NPCs expressing OTX2 (green) and PAX6 (red). Nuclei are stained with DAPI (blue). Scale bars represent 100 μm. Bottom: qRT-PCR and flow cytometry analyses of OCT3/4, PAX6, SOX1. The expression of FUT1 and α-fucose in iPSCs during pluripotency and differentiation is identical to that of hESCs ( D ) Quantification of the percent of positive cells expressing both the FT1 and OCT3/4 proteins and MFI in hESCs, a pool of hiPSCs and a pool of human fibroblasts. Pooled sample, n = 3 cell lines. n = 3 technical replicates. ( E ) Quantification of the percent of positive cells expressing FT1 protein and α-fucose residues and MFI in hESCs, a pool of hiPSCs, and a pool of human fibroblasts. Pooled sample, n = 3 cell lines. n = 3 technical replicates. Data information: In qPCR ( A , B ), data are presented as means ± SD. Two-tailed Student’s t-tests * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. In FACS ( A – E ), data are presented as means ± SD. Ordinary One-way ANOVA ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Article Snippet: HHEX , Hematopoietically-expressed homeobox , HHEX , Hs01074519_m1.

Techniques: Gene Expression, Derivative Assay, Expressing, Inhibition, Staining, Quantitative RT-PCR, Flow Cytometry, Two Tailed Test

( A ) Left: Representative histograms showing counts and MFI of FUT1 positive hESCs (FUT1 + ECs) expressing Globo-H compared to WT hESCs. Center: Representative images showing hESC nuclei (blue) and Globo-H expression (green). Right: Representative histograms showing counts and MFI of FUT1 + ECs expressing SSEA-5 compared to hESCs. n = 3 biological replicates. ( B ) Left: Pluripotent NANOG, SOX2, and OCT3/4 mRNA expression levels in WT hESCs, control hESCs (control) and FUT1 + ECs, three passages after mock and FUT1 transfection, respectively. n = 3 clones for each clone n = 2 technical replicates. Right top: Representative bright-field and endogenous fluorescence protein (green) images of control colony morphology after one passage in culture, on day 3. Right bottom: Representative bright-field and endogenous fluorescence protein (green) images of FUT1 + EC colony morphology after one passage in culture, on day 3. n = 2 technical replicates. ( C ) mRNA expression levels of pluripotent OCT3/4 and mesoderm-specific markers, MESP1 and BRY, in WT hESCs, control, and FUT1 + ECs, on day 0 and after differentiation into LM for 1 d. n = 3 clones for each clone n = 2 technical replicates. ( D ) Top: mRNA expression levels of mesoderm-specific markers, FOXF1, IRX3, and HAND1 in WT hESCs, control, and FUT1 + ECs on day 0 and after differentiation into LM for 2 d. n = 3 clones for each clone n = 2 technical replicates. Bottom: Representative histograms showing relative counts of WT hESCs and FUT1 + ECs expressing HAND1 protein and quantification of the percent of positive cells for HAND1 in WT hESCs and FUT1 + ECs after LM differentiation for 3 d. n = 3 technical replicates. ( E ) Top: mRNA expression levels of mesoderm-specific markers, NKX2.5, ISL1, and HOPX in WT hESCs, control, and FUT1 + ECs on day 0 and after differentiation into LM for 3 d. n = 3 clones for each clone n = 2 technical replicates. Bottom: Representative histograms showing relative counts of WT hESCs and FUT1 + ECs expressing HOPX protein and quantification of the percent of positive cells for HOPX in WT hESCs and FUT1 + ECs after differentiation into LM for 3 d. Pools of FUT1 + ECs were used for FACS. n = 3 technical replicates. ( F ) Top Left: Schematic showing hESC differentiation into DE over three days by using the protocol of (Loh et al, ). Top right: mRNA expression levels of endoderm-specific markers, HHEX, FOXA2, and SOX17 in WT hESCs, control, and FUT1 + ECs on day 0 and after differentiation into DE for 3 d, as measured by qPCR. n = 2 clones for each clone n = 3 technical replicates. Bottom: Representative histograms showing relative counts of WT hESCs and FUT1 + ECs expressing SOX17 protein and quantification of the fraction of positive cells for SOX17 in WT hESCs and FUT1 + ECs after differentiation into DE for 3 d. n = 3 technical replicates. ( G ) Left: mRNA expression levels of Ectoderm-specific marker, PAX6 in WT hESCs, control, and FUT1 + ECs on day 0 and after differentiation into NPCs for 3 d, as measured by qPCR. n = 2 clones for each clone n = 3 technical replicates. Center: Representative histograms showing relative counts of WT hESCs and FUT1 + ECs expressing PAX6 protein of the fraction of positive cells for PAX6 in WT hESCs and FUT1 + ECs after differentiation into NPCs for 3 d. n = 3 technical replicates. Right: Quantification of positive cells for PAX6 in WT hESCs and FUT1 + ECs after differentiation into NPCs for 3 d. n = 2 clones for each clone n = 2 technical replicates. ( H ) Left: Representative histograms showing relative counts of control and FUT1 + ECs expressing cTnT protein after differentiation into CMs for 20 d. n = 2 clones for each clone n = 3 technical replicates. Left at center: Quantification of the fraction of positive cells for cTnT in control and FUT1 + ECs after differentiation into CMs for 20 d. Left at right: MFI of control and FUT1 + ECs expressing cTnT after differentiation into CMs for 20 d. n = 2 clones for each clone n = 3 technical replicates, Right at left: Representative histograms showing relative counts of control and FUT1 + ECs expressing Myosin protein after differentiation into CMs for 20 d. n = 2 clones for each clone n = 3 technical replicates. Right at center: Quantification of the fraction of positive cells for Myosin in control and FUT1 + ECs after differentiation into CMs for 20 d. Right at right: MFI of control and FUT1 + ECs expressing Myosin after differentiation into CMs for 20 d. n = 2 clones for each clone n = 3 technical replicates. ( I ) Left: Quantification of cardiac marker, TNNT2 mRNA expression in control and FUT1 + ECs on day 0 and after CM differentiation for 20 d, as measured by qPCR. Right: Quantification of cardiac marker, ACTC1 mRNA expression in control and FUT1 + ECs on day 0 and after CM differentiation for 20 d, as measured by qPCR. The housekeeping gene GAPDH, was used for normalization. n = 2 clones for each clone n = 3 technical replicates. More than n = 7 clones of control hESCs and FUT1 + ECs were generated for overexpression experiments; mRNA expression of n = 3 clones was measured by qPCR. Pools and n = 2 clones of control hESCs and FUT1 + ECs originating from WA09-transfected hESCs after sorting were used for imaging and FACS. n = 2 clones of control and FUT1 + ECs were differentiated into CMs and measured by qPCR and FACS. Data presented are relative to the values of day 0 WT hESCs. Data information: In ( A , B ), scale bars represent 100 μm. In ( A – F ), data are presented as means ± SDs. Two-tailed Student’s t-tests * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 or non-significant (NS). In ( G ), data are presented as means ± SDs. Ordinary one-way ANOVA ** P < 0.01 or non-significant (NS), and for PAX 6, Two-tailed Student’s t -test * p < 0.05. In ( H ), data are presented as means ± SDs. Two-tailed Student’s t-tests * p < 0.05, ** p < 0.01, and for Myosin, Ordinary one-way ANOVA ** p < 0.01, **** p < 0.0001. In ( I ), Data are presented as means ± SEM. Two-tailed Student’s t-tests * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Journal: EMBO Reports

Article Title: Terminal α1,2-fucosylation of glycosphingolipids by FUT1 is a key regulator in early cell-fate decisions

doi: 10.1038/s44319-024-00243-1

Figure Lengend Snippet: ( A ) Left: Representative histograms showing counts and MFI of FUT1 positive hESCs (FUT1 + ECs) expressing Globo-H compared to WT hESCs. Center: Representative images showing hESC nuclei (blue) and Globo-H expression (green). Right: Representative histograms showing counts and MFI of FUT1 + ECs expressing SSEA-5 compared to hESCs. n = 3 biological replicates. ( B ) Left: Pluripotent NANOG, SOX2, and OCT3/4 mRNA expression levels in WT hESCs, control hESCs (control) and FUT1 + ECs, three passages after mock and FUT1 transfection, respectively. n = 3 clones for each clone n = 2 technical replicates. Right top: Representative bright-field and endogenous fluorescence protein (green) images of control colony morphology after one passage in culture, on day 3. Right bottom: Representative bright-field and endogenous fluorescence protein (green) images of FUT1 + EC colony morphology after one passage in culture, on day 3. n = 2 technical replicates. ( C ) mRNA expression levels of pluripotent OCT3/4 and mesoderm-specific markers, MESP1 and BRY, in WT hESCs, control, and FUT1 + ECs, on day 0 and after differentiation into LM for 1 d. n = 3 clones for each clone n = 2 technical replicates. ( D ) Top: mRNA expression levels of mesoderm-specific markers, FOXF1, IRX3, and HAND1 in WT hESCs, control, and FUT1 + ECs on day 0 and after differentiation into LM for 2 d. n = 3 clones for each clone n = 2 technical replicates. Bottom: Representative histograms showing relative counts of WT hESCs and FUT1 + ECs expressing HAND1 protein and quantification of the percent of positive cells for HAND1 in WT hESCs and FUT1 + ECs after LM differentiation for 3 d. n = 3 technical replicates. ( E ) Top: mRNA expression levels of mesoderm-specific markers, NKX2.5, ISL1, and HOPX in WT hESCs, control, and FUT1 + ECs on day 0 and after differentiation into LM for 3 d. n = 3 clones for each clone n = 2 technical replicates. Bottom: Representative histograms showing relative counts of WT hESCs and FUT1 + ECs expressing HOPX protein and quantification of the percent of positive cells for HOPX in WT hESCs and FUT1 + ECs after differentiation into LM for 3 d. Pools of FUT1 + ECs were used for FACS. n = 3 technical replicates. ( F ) Top Left: Schematic showing hESC differentiation into DE over three days by using the protocol of (Loh et al, ). Top right: mRNA expression levels of endoderm-specific markers, HHEX, FOXA2, and SOX17 in WT hESCs, control, and FUT1 + ECs on day 0 and after differentiation into DE for 3 d, as measured by qPCR. n = 2 clones for each clone n = 3 technical replicates. Bottom: Representative histograms showing relative counts of WT hESCs and FUT1 + ECs expressing SOX17 protein and quantification of the fraction of positive cells for SOX17 in WT hESCs and FUT1 + ECs after differentiation into DE for 3 d. n = 3 technical replicates. ( G ) Left: mRNA expression levels of Ectoderm-specific marker, PAX6 in WT hESCs, control, and FUT1 + ECs on day 0 and after differentiation into NPCs for 3 d, as measured by qPCR. n = 2 clones for each clone n = 3 technical replicates. Center: Representative histograms showing relative counts of WT hESCs and FUT1 + ECs expressing PAX6 protein of the fraction of positive cells for PAX6 in WT hESCs and FUT1 + ECs after differentiation into NPCs for 3 d. n = 3 technical replicates. Right: Quantification of positive cells for PAX6 in WT hESCs and FUT1 + ECs after differentiation into NPCs for 3 d. n = 2 clones for each clone n = 2 technical replicates. ( H ) Left: Representative histograms showing relative counts of control and FUT1 + ECs expressing cTnT protein after differentiation into CMs for 20 d. n = 2 clones for each clone n = 3 technical replicates. Left at center: Quantification of the fraction of positive cells for cTnT in control and FUT1 + ECs after differentiation into CMs for 20 d. Left at right: MFI of control and FUT1 + ECs expressing cTnT after differentiation into CMs for 20 d. n = 2 clones for each clone n = 3 technical replicates, Right at left: Representative histograms showing relative counts of control and FUT1 + ECs expressing Myosin protein after differentiation into CMs for 20 d. n = 2 clones for each clone n = 3 technical replicates. Right at center: Quantification of the fraction of positive cells for Myosin in control and FUT1 + ECs after differentiation into CMs for 20 d. Right at right: MFI of control and FUT1 + ECs expressing Myosin after differentiation into CMs for 20 d. n = 2 clones for each clone n = 3 technical replicates. ( I ) Left: Quantification of cardiac marker, TNNT2 mRNA expression in control and FUT1 + ECs on day 0 and after CM differentiation for 20 d, as measured by qPCR. Right: Quantification of cardiac marker, ACTC1 mRNA expression in control and FUT1 + ECs on day 0 and after CM differentiation for 20 d, as measured by qPCR. The housekeeping gene GAPDH, was used for normalization. n = 2 clones for each clone n = 3 technical replicates. More than n = 7 clones of control hESCs and FUT1 + ECs were generated for overexpression experiments; mRNA expression of n = 3 clones was measured by qPCR. Pools and n = 2 clones of control hESCs and FUT1 + ECs originating from WA09-transfected hESCs after sorting were used for imaging and FACS. n = 2 clones of control and FUT1 + ECs were differentiated into CMs and measured by qPCR and FACS. Data presented are relative to the values of day 0 WT hESCs. Data information: In ( A , B ), scale bars represent 100 μm. In ( A – F ), data are presented as means ± SDs. Two-tailed Student’s t-tests * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 or non-significant (NS). In ( G ), data are presented as means ± SDs. Ordinary one-way ANOVA ** P < 0.01 or non-significant (NS), and for PAX 6, Two-tailed Student’s t -test * p < 0.05. In ( H ), data are presented as means ± SDs. Two-tailed Student’s t-tests * p < 0.05, ** p < 0.01, and for Myosin, Ordinary one-way ANOVA ** p < 0.01, **** p < 0.0001. In ( I ), Data are presented as means ± SEM. Two-tailed Student’s t-tests * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Article Snippet: HHEX , Hematopoietically-expressed homeobox , HHEX , Hs01074519_m1.

Techniques: Expressing, Control, Transfection, Clone Assay, Fluorescence, Marker, Generated, Over Expression, Imaging, Two Tailed Test

Reagents and tools table

Journal: EMBO Reports

Article Title: Terminal α1,2-fucosylation of glycosphingolipids by FUT1 is a key regulator in early cell-fate decisions

doi: 10.1038/s44319-024-00243-1

Figure Lengend Snippet: Reagents and tools table

Article Snippet: HHEX , Hematopoietically-expressed homeobox , HHEX , Hs01074519_m1.

Techniques: Immunohistochemistry-Frozen IF, Western Blot, Recombinant, Staining, Plasmid Preparation, Sequencing, Control, Transfection, Over Expression, Software, TaqMan Assay, Gene Expression, Binding Assay, Marker

mRNA and protein expression of HHEX. ( A ) mRNA expression in controls, multiple sclerosis (MS) patients, and MS patients stratified by treatment. Controls: n = 117; MS patients: n = 154; MS patients treated with IFN-β: n = 94; MS patients treated with glatiramer acetate: n = 57. ( B ) HHEX mRNA expression in controls and MS patients stratified by rs7923837 genotype. Heterozygotes were grouped with major homozygotes due to similar expression levels. Control GG + GA: n = 101; minor allele homozygous controls AA: n = 16; MS GG + GA: n = 133; MS AA: n = 18; MS GG + GA treated with IFN-β: n = 85; MS AA treated with IFN-β: n = 9; MS GG + GA treated with glatiramer acetate: n = 48; MS AA treated with glatiramer acetate: n = 9. ( C ) Expression of HHEX protein analyzed by Western blot, stratified by rs7923837 genotype. Control GG + GA: n = 24; Control AA: n = 9; MS GG + GA: n = 36; MS AA: n = 13. Mean and standard deviation are presented in all panels.

Journal: International Journal of Molecular Sciences

Article Title: Unraveling the Influence of HHEX Risk Polymorphism rs7923837 on Multiple Sclerosis Pathogenesis

doi: 10.3390/ijms23147956

Figure Lengend Snippet: mRNA and protein expression of HHEX. ( A ) mRNA expression in controls, multiple sclerosis (MS) patients, and MS patients stratified by treatment. Controls: n = 117; MS patients: n = 154; MS patients treated with IFN-β: n = 94; MS patients treated with glatiramer acetate: n = 57. ( B ) HHEX mRNA expression in controls and MS patients stratified by rs7923837 genotype. Heterozygotes were grouped with major homozygotes due to similar expression levels. Control GG + GA: n = 101; minor allele homozygous controls AA: n = 16; MS GG + GA: n = 133; MS AA: n = 18; MS GG + GA treated with IFN-β: n = 85; MS AA treated with IFN-β: n = 9; MS GG + GA treated with glatiramer acetate: n = 48; MS AA treated with glatiramer acetate: n = 9. ( C ) Expression of HHEX protein analyzed by Western blot, stratified by rs7923837 genotype. Control GG + GA: n = 24; Control AA: n = 9; MS GG + GA: n = 36; MS AA: n = 13. Mean and standard deviation are presented in all panels.

Article Snippet: Cells were stained with rabbit anti-human HHEX (HPA055460, Atlas Antibodies, Bromma, Sweden) as primary antibody, and a combination of biotinylated anti-rabbit antibody (BA-1000, Vector Laboratories, Newark, CA, USA) and streptavidin-Alexa Fluor 555 (S32355, Invitrogen, Waltham, MA, USA) supplemented with Draq5 (ab108410, Abcam, Cambridge, United Kingdom).

Techniques: Expressing, Control, Western Blot, Standard Deviation

Subcellular localization of HHEX by confocal microscopy and epistatic interaction HHEX - BCL6 . ( A ) Immunofluorescence of HHEX by confocal microscopy shows a higher localization of the transcription factor in the nucleus in rs7923837*AA multiple sclerosis (MS) patients. One confocal plane of each condition is shown. ( B ) Cytoplasmic/nuclear HHEX ratio measured by immunofluorescence and stratified by rs7923837 genotypes. Control carriers of the major allele GG + GA: n = 320 cells from 8 subjects; minor allele homozygous controls AA: n = 128 cells from 4 subjects; MS GG + GA: n = 599 cells from 17 subjects; and MS AA: n = 256 cells from 8 subjects. Red lines represent the median of the distribution (Control GG + GA median = 0.48; Control AA median = 0.56; MS GG + GA median = 0.52; MS AA median = 0.39). ( C ) HHEX mRNA expression stratified by the MS-risk polymorphism located near BCL6 , rs2590438. Control carriers of the major allele TT + GT: n = 38; minor allele homozygous controls GG: n = 9; MS TT + GT: n = 40; and MS GG: n = 6. Mean and standard deviation are presented.

Journal: International Journal of Molecular Sciences

Article Title: Unraveling the Influence of HHEX Risk Polymorphism rs7923837 on Multiple Sclerosis Pathogenesis

doi: 10.3390/ijms23147956

Figure Lengend Snippet: Subcellular localization of HHEX by confocal microscopy and epistatic interaction HHEX - BCL6 . ( A ) Immunofluorescence of HHEX by confocal microscopy shows a higher localization of the transcription factor in the nucleus in rs7923837*AA multiple sclerosis (MS) patients. One confocal plane of each condition is shown. ( B ) Cytoplasmic/nuclear HHEX ratio measured by immunofluorescence and stratified by rs7923837 genotypes. Control carriers of the major allele GG + GA: n = 320 cells from 8 subjects; minor allele homozygous controls AA: n = 128 cells from 4 subjects; MS GG + GA: n = 599 cells from 17 subjects; and MS AA: n = 256 cells from 8 subjects. Red lines represent the median of the distribution (Control GG + GA median = 0.48; Control AA median = 0.56; MS GG + GA median = 0.52; MS AA median = 0.39). ( C ) HHEX mRNA expression stratified by the MS-risk polymorphism located near BCL6 , rs2590438. Control carriers of the major allele TT + GT: n = 38; minor allele homozygous controls GG: n = 9; MS TT + GT: n = 40; and MS GG: n = 6. Mean and standard deviation are presented.

Article Snippet: Cells were stained with rabbit anti-human HHEX (HPA055460, Atlas Antibodies, Bromma, Sweden) as primary antibody, and a combination of biotinylated anti-rabbit antibody (BA-1000, Vector Laboratories, Newark, CA, USA) and streptavidin-Alexa Fluor 555 (S32355, Invitrogen, Waltham, MA, USA) supplemented with Draq5 (ab108410, Abcam, Cambridge, United Kingdom).

Techniques: Confocal Microscopy, Immunofluorescence, Control, Expressing, Standard Deviation

Glycolytic profile and mitochondrial mass of PBMCs from multiple sclerosis (MS) patients and controls stratified by the genotypes of HHEX rs7923837. ( A ) Energy phenotype of the studied groups. Minimum and maximum values of extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) were confronted to obtain an estimation of the metabolic range of the cells. ( B – D ) Glycolytic analysis comparing carriers of the major allele in HHEX rs7923837 and minor-allele homozygotes from both MS patients and controls. Control GG + GA: n = 11; Control AA: n = 7; MS GG + GA: n = 18; MS AA: n = 7. ( E – H ) Increase in mitochondrial mass measured by flow cytometry with Mitotracker Green TM after activation with PHA. The ratio of the median fluorescence intensity in the presence/absence of PHA was calculated for PBMCs ( E ) and the indicated lymphocyte subpopulations ( F – H ). Control GG + GA: n = 9; Control AA: n = 5; MS GG + GA: n = 17; MS AA: n = 8. Mean and standard deviation are presented in panels ( B – H ).

Journal: International Journal of Molecular Sciences

Article Title: Unraveling the Influence of HHEX Risk Polymorphism rs7923837 on Multiple Sclerosis Pathogenesis

doi: 10.3390/ijms23147956

Figure Lengend Snippet: Glycolytic profile and mitochondrial mass of PBMCs from multiple sclerosis (MS) patients and controls stratified by the genotypes of HHEX rs7923837. ( A ) Energy phenotype of the studied groups. Minimum and maximum values of extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) were confronted to obtain an estimation of the metabolic range of the cells. ( B – D ) Glycolytic analysis comparing carriers of the major allele in HHEX rs7923837 and minor-allele homozygotes from both MS patients and controls. Control GG + GA: n = 11; Control AA: n = 7; MS GG + GA: n = 18; MS AA: n = 7. ( E – H ) Increase in mitochondrial mass measured by flow cytometry with Mitotracker Green TM after activation with PHA. The ratio of the median fluorescence intensity in the presence/absence of PHA was calculated for PBMCs ( E ) and the indicated lymphocyte subpopulations ( F – H ). Control GG + GA: n = 9; Control AA: n = 5; MS GG + GA: n = 17; MS AA: n = 8. Mean and standard deviation are presented in panels ( B – H ).

Article Snippet: Cells were stained with rabbit anti-human HHEX (HPA055460, Atlas Antibodies, Bromma, Sweden) as primary antibody, and a combination of biotinylated anti-rabbit antibody (BA-1000, Vector Laboratories, Newark, CA, USA) and streptavidin-Alexa Fluor 555 (S32355, Invitrogen, Waltham, MA, USA) supplemented with Draq5 (ab108410, Abcam, Cambridge, United Kingdom).

Techniques: Control, Flow Cytometry, Activation Assay, Fluorescence, Standard Deviation

Quantitative real-time reverse transcription polymerase chain reaction analysis of the CSNK2A1 gene in the liver tissues of control (+Dock7 m /+Dock7 m ) and T2DM (+Lepr db /+Lepr db ) mice at 4, 16, and 32 weeks. Gene expression data of CSNK2A1 was calculated after normalizing against GADPH (**, P < 0.05).

Journal: International Journal of Medical Sciences

Article Title: Effects of Casein Kinase 2 Alpha 1 Gene Expression on Mice Liver Susceptible to Type 2 Diabetes Mellitus and Obesity

doi: 10.7150/ijms.37110

Figure Lengend Snippet: Quantitative real-time reverse transcription polymerase chain reaction analysis of the CSNK2A1 gene in the liver tissues of control (+Dock7 m /+Dock7 m ) and T2DM (+Lepr db /+Lepr db ) mice at 4, 16, and 32 weeks. Gene expression data of CSNK2A1 was calculated after normalizing against GADPH (**, P < 0.05).

Article Snippet: All tissue sections were de-waxed, treated with Proteinase K enzyme, and the endogenous peroxidase activity was blocked by incubating with 3% hydrogen peroxide for 10 min. After washing with phosphate-buffered saline (PBS; pH 7.6) for 5 min, the slides were incubated with anti-CSNK2A1 antibodies (GTX84369; GeneTex, Hsinchu, Taiwan) for 30 min at 37 °C, followed by rabbit anti-rat antibodies and a goat anti-rabbit HRP polymer for 15 min.

Techniques: Reverse Transcription, Polymerase Chain Reaction, Control, Gene Expression

(A) Western blot analyses of CSNK2A1 protein expression in the liver tissues of control (+Dock7 m /+Dock7 m ; lanes 1, 3, and 5) and T2DM (+Lepr db /+Lepr db ; lanes 2, 4, and 6) mice at 4, 16, and 32 weeks, respectively. (B) Representative IHC-processed CSNK2A1 expression in T2DM mice (+Lepr db /+Lepr db ) is shown. Progression of the mouse models for T2DM is also shown. Liver tissues were excised, fixed, embedded, and sectioned for IHC staining as described in the Materials and Methods.

Journal: International Journal of Medical Sciences

Article Title: Effects of Casein Kinase 2 Alpha 1 Gene Expression on Mice Liver Susceptible to Type 2 Diabetes Mellitus and Obesity

doi: 10.7150/ijms.37110

Figure Lengend Snippet: (A) Western blot analyses of CSNK2A1 protein expression in the liver tissues of control (+Dock7 m /+Dock7 m ; lanes 1, 3, and 5) and T2DM (+Lepr db /+Lepr db ; lanes 2, 4, and 6) mice at 4, 16, and 32 weeks, respectively. (B) Representative IHC-processed CSNK2A1 expression in T2DM mice (+Lepr db /+Lepr db ) is shown. Progression of the mouse models for T2DM is also shown. Liver tissues were excised, fixed, embedded, and sectioned for IHC staining as described in the Materials and Methods.

Article Snippet: All tissue sections were de-waxed, treated with Proteinase K enzyme, and the endogenous peroxidase activity was blocked by incubating with 3% hydrogen peroxide for 10 min. After washing with phosphate-buffered saline (PBS; pH 7.6) for 5 min, the slides were incubated with anti-CSNK2A1 antibodies (GTX84369; GeneTex, Hsinchu, Taiwan) for 30 min at 37 °C, followed by rabbit anti-rat antibodies and a goat anti-rabbit HRP polymer for 15 min.

Techniques: Western Blot, Expressing, Control, Immunohistochemistry

ELISA-mediated measurement of CSNK2A1 protein levels in the liver tissues of control (+Dock7 m /+Dock7 m ) and T2DM (+Lepr db /+Lepr db ) mice at 4, 16, and 32 weeks. **, P < 0.05 for the indicated comparisons.

Journal: International Journal of Medical Sciences

Article Title: Effects of Casein Kinase 2 Alpha 1 Gene Expression on Mice Liver Susceptible to Type 2 Diabetes Mellitus and Obesity

doi: 10.7150/ijms.37110

Figure Lengend Snippet: ELISA-mediated measurement of CSNK2A1 protein levels in the liver tissues of control (+Dock7 m /+Dock7 m ) and T2DM (+Lepr db /+Lepr db ) mice at 4, 16, and 32 weeks. **, P < 0.05 for the indicated comparisons.

Article Snippet: All tissue sections were de-waxed, treated with Proteinase K enzyme, and the endogenous peroxidase activity was blocked by incubating with 3% hydrogen peroxide for 10 min. After washing with phosphate-buffered saline (PBS; pH 7.6) for 5 min, the slides were incubated with anti-CSNK2A1 antibodies (GTX84369; GeneTex, Hsinchu, Taiwan) for 30 min at 37 °C, followed by rabbit anti-rat antibodies and a goat anti-rabbit HRP polymer for 15 min.

Techniques: Enzyme-linked Immunosorbent Assay, Control

ELISA-mediated measurement of CSNK2A1 protein levels in the human serum of T2DM patients and controls.

Journal: International Journal of Medical Sciences

Article Title: Effects of Casein Kinase 2 Alpha 1 Gene Expression on Mice Liver Susceptible to Type 2 Diabetes Mellitus and Obesity

doi: 10.7150/ijms.37110

Figure Lengend Snippet: ELISA-mediated measurement of CSNK2A1 protein levels in the human serum of T2DM patients and controls.

Article Snippet: All tissue sections were de-waxed, treated with Proteinase K enzyme, and the endogenous peroxidase activity was blocked by incubating with 3% hydrogen peroxide for 10 min. After washing with phosphate-buffered saline (PBS; pH 7.6) for 5 min, the slides were incubated with anti-CSNK2A1 antibodies (GTX84369; GeneTex, Hsinchu, Taiwan) for 30 min at 37 °C, followed by rabbit anti-rat antibodies and a goat anti-rabbit HRP polymer for 15 min.

Techniques: Enzyme-linked Immunosorbent Assay